HMGCS2 and diabetic cardiomyopathy: Hmgcs2 overexpression was reported to promote cardiomyocyte apoptosis, inflammation, and oxidative stress, whereas its silencing attenuates these effects in diabetic cardiomyopathy cell models [33].